The C. DIFF CHEK™ - 60 test is an enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected…
The C. DIFF CHEK™ – 60 test is an enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile disease. The test does not distinguish toxigenic from nontoxigenic strains of C. difficile. With the use of additional tests that detect C. difficile toxins, this test is to be used as an aid in the diagnosis of C. difficile disease. As with other C. difficile tests, results should be considered in conjunction with patient history.
Who Else Makes It
Registered in Jiangsu.
Record
Regulatory record for C. Diff Chek – 60 | Listed by | Techlab, Inc., United States |
| FDA product code | LLH |
| Device type | Reagents, Clostridium Difficile Toxin |
| Device class | Class 1 |
| Regulation | 21 CFR 866.2660 |
| Establishment | Manufacturer |
| 510(k) | K030992 |
| Record published | 2021-05-03 |
| Record revised | 2023-08-15 (version 2) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date |
| Distribution end date | 2021-07-26 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.